Physician profile
Tarek Hammad
NPI 1912212135
$41,625.74
in general payments reported to CMS, 2019-2025
29 companies · $808 in 2025
The $808 reported for 2025 was more than what 94% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $491 · 2020: $21K · 2021: $867 · 2022: $6,566 · 2023: $10K · 2024: $1,127 · 2025: $808.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,375 · Food and Beverage: $3,478 · Travel and Lodging: $1,310 · Consulting Fee: $1,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,375.00 |
| Food and Beverage | $3,477.90 |
| Travel and Lodging | $1,309.80 |
| Consulting Fee | $1,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $21,269.75 | 2019-2020 | |
| Medtronic, INC. | $14,464.60 | 2021-2025 | Onyx Frontier, In.Pact Admiral, Endurant Iis |
| Boston Scientific Corporation | $2,879.32 | 2020-2025 | Opticross, Avvigo Guidance System, Eluvia |
| Abbott Laboratories | $1,268.60 | 2019-2024 | Esprit, Jeti All In One Non-Sterile Kit, Dragonfly Opstar |
| Stryker Corporation | $296.96 | 2024-2025 | Actishield, Clottriever Bold Catheter, Artix Mt |
| Abiomed | $252.56 | 2019-2023 | Impella |
| Janssen Pharmaceuticals, INC | $226.34 | 2021-2024 | Xarelto |
| Surmodics, INC. | $186.98 | 2025 | Pounce Thrombectomy, Pounce Xl Thrombectomy, Pounce LP Thrombectomy |
| Penumbra, INC. | $116.06 | 2021 | |
| Novartis Pharmaceuticals Corporation | $96.05 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.34 | 2022-2025 | Jardiance, Ofev |
| Esperion Therapeutics, INC. | $73.18 | 2025 | Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $55.77 | 2019-2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $46.89 | 2021-2024 | Eliquis |
| Cordis US Corp. | $41.08 | 2023 | Saber, Mynx Control |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $37.62 | 2022-2023 | Strensiq |
| Pfizer INC. | $28.68 | 2021-2024 | |
| Mallinckrodt Hospital Products INC. | $25.18 | 2023 | Acthar |
| Genentech USA, INC. | $21.89 | 2023 | Actemra |
| Shockwave Medical, INC | $21.79 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $20.58 | 2019 | |
| Lundbeck LLC | $17.81 | 2019 | |
| Philips North America LLC | $15.78 | 2022 | |
| Novo Nordisk INC | $15.53 | 2024 | Wegovy |
| Sanofi-Aventis U.S. LLC | $15.13 | 2022 | |
| Merck Sharp & Dohme LLC | $14.89 | 2021 | |
| Amgen INC. | $14.80 | 2021 | |
| Abbvie INC. | $13.40 | 2022 | |
| Sobi, INC | $12.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tarek Hammad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.